Abstract
In addition to PAH-specific therapies proven to be effective in achieving a better outcome and/or symptomatic improvement, the care of patients with pulmonary arterial hypertension (PAH) requires a complex strategy that includes general pharmacological and non-pharmacological measures. This chapter will detail the general supportive measures beneficial for PAH patients as adjuvant treatment to targeted therapies.
This is a preview of subscription content, log in via an institution to check access.
References
Atz AM, Adatia I et al (1999) Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol 33(3):813–819
Bendayan D, Hod M et al (2005) Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol 106(5 Pt 2):1206–1210
Bonnin M, Mercier FJ et al (2005) Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102(6):1133–1137, discussion 1135A–1136A
Chambers CD, Hernandez-Diaz S et al (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–587
de Man FS, Handoko ML et al (2009) Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 34(3):669–675
Fox BD, Kassirer M et al (2011) Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail 17(3):196–200
Fuster V, Steele PM et al (1984) Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70(4):580–587
Grunig E, Lichtblau M et al (2012) Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J 40(1):84–92
Hamaguchi S, Kinugawa S et al (2010) Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure. Am Heart J 160(6):1156–1162
Jais X, Olsson KM et al (2012) Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 40(4):881–885
Januzzi JL Jr, Rehman SU et al (2011) Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol 58(18):1881–1889
Kaw R, Pasupuleti V et al (2011) Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respir Med 105(4):619–624
Kawut SM, Horn EM et al (2005) New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 95(2):199–203
Kieler H, Artama M et al (2012) Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 344:d8012
Mauritz GJ, Rizopoulos D et al (2011) Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol 108(11):1645–1650
Mereles D, Ehlken N et al (2006) Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 114(14):1482–1489
Meyer S, McLaughlin VV et al (2013) Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 41(6):1302–1307
Minai OA, Venkateshiah SB et al (2006) Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med 70(4):239–243
Minai OA, Pandya CM et al (2007) Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest 131(1):109–117
Rich S, Kaufmann E et al (1992) The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 327(2):76–81
Rich S, Seidlitz M et al (1998) The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 114(3):787–792
Roubinian N, Elliott CG et al (2012) Effects of commercial air travel on patients with pulmonary hypertension. Chest 142(4):885–892
Sadoughi A, Roberts KE et al (2013) Use of selective serotonin uptake inhibitors and outcomes in pulmonary arterial hypertension. Chest. doi: 10.1378/chest.12-2081
Sandoval J, Aguirre JS et al (2001) Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med 164(9):1682–1687
Shah SJ, Gomberg-Maitland M et al (2009) Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension. Chest 136(3):694–700
Thamm M, Voswinckel R et al (2011) Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension. Pulm Circ 1(2):239–243
Wagenvoort CA (1980) Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 77(5):614–625
Weitzenblum E, Sautegeau A et al (1985) Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 131(4):493–498
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Preston, I.R. (2013). General Supportive Care. In: Humbert, M., Evgenov, O., Stasch, JP. (eds) Pharmacotherapy of Pulmonary Hypertension. Handbook of Experimental Pharmacology, vol 218. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38664-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-38664-0_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38663-3
Online ISBN: 978-3-642-38664-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)